Lv5
860 积分 2024-10-12 加入
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
2天前
已完结
BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy
6天前
已完结
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
6天前
已完结
POS1160 A PHASE IB, MULTICENTRE, OPEN-LABEL, DOSE-ESCALATION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SUBCUTANEOUSLY ADMINISTERED MOSUNETUZUMAB IN PARTICIPANTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
6天前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
7天前
已完结
KT501, A CD19, BCMA-DIRECTED T-CELL ENGAGER (TCE), LEADS TO DEEP B-CELL DEPLETION AND MINIMAL CYTOKINE RELEASE IN VIVO
21天前
已关闭
TREM2 is a sensor of lipid ligands that regulates macrophage inflammation and homeostasis
27天前
已关闭
Cutting Edge: TREM-2 Attenuates Macrophage Activation1
27天前
已完结
Triggering receptor expressed on myeloid cells-2 protects against polymicrobial sepsis by enhancing bacterial clearance
27天前
已完结
Positive results for obinutuzumab in SLE phase III trial
1个月前
已关闭
皖公网安备34019202002308
